2011•Faculty Opinions – Post-Publication Peer Review of the Biomedical LiteratureRequires access

Faculty Opinions recommendation of Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.

Kiat Ruxrungtham, Wirach Maek-a-nantawat

Abstract

Read the full review for this Faculty Opinions recommended article: Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rilpivirine, Emtricitabine, Efavirenz, Tenofovir, Medicine, Human immunodeficiency virus (HIV), Echo (communications protocol), Double blind